Hirudoid 100 crem
.
1 Therapeutic indications
Designated by:
- Adjuvant Treatment of hematoma, bruising, swelling, edema.
-- Prevention and treatment of superficial thrombophlebitis and infiltration by intravenous infusions or injections.
2. KWALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient: mucopolysaccharides polysulphated 300 mg per 100 g.
For excipients, see section 6.1
3. PHARMACEUTICAL FORM
HIRUDOID is in the form of gel and the form of cream , externally, cutaneous use.
4.2 Posology and method of administration
Several times a day 3 to 5 cm gel or cream (or if necessary more, for example at the beginning of treatment) on and around the affected area application. The gel on the skin evenly distribute the light massage cream. At very painful inflammation or in the presence of thrombus, HIRUDOID cream gently divide the affected area and surrounding it, and then cover with a gauze compress eg. Given his alcohol content may not be related HIRUDOID gel be applied. HIRUDOID is suitable for phonograms and Iontophoretic (applying to the negative pole).
This is a medicine, no prolonged use without medical advice, keep out of reach children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.
4.3 Contra-indications:
Hypersensitivity to poly-sulphate mucopolysaccharides, heparin or heparinoids or other ingredients of the medicine.
eczematous dermatitis.
not apply in cases of infected skin lesions in the affected skin area.
4.4 Special warnings and precautions for use:
HIRUDOID Avoid contact with open wounds, eyes or mucous membranes.
HIRUDOID Cream
contains:
- cetostearyl alcohol which may cause local skin reactions (eg contact).
- methyl (E218) and propyl (E216): these compounds may trigger allergic reactions (possibly after a certain period).
HIRUDOID Gel
includes:
- propylene glycol, which irritation of the skin may cause.
4.6 Pregnancy and lactation
The clinical experience does not suggest teratogenic effects. While no objective data available, however, we avoid applying HIRUDOID large areas of skin during pregnancy and lactation.
4.8 Undesirable
Stoornissenvan the skin and subcutaneous tissues: Rare (between 1/10.000 and 1/1.000): hypersensitivity reactions occur in the form of erythema. Usually these symptoms disappear after treatment interruption, which in this case is called.
4.7. Effects on ability to drive and use machines
Not applicable.
4.9. Overdose
The relatively small amount of active ingredient in a tube HIRUDOID excludes the possibility of an overdose.
6.1 List of excipients
HIRUDOID Cream:
Glycerol (85%) - Wolvetalcoholenzalf Stearic Acid - Emulsifier cetostearyl alcohol (type A) - Myristyl - Isopropyl alcohol - Potassium hydroxide - Thymol - Methyl (E218) - Propyl (E216) - Purified water qs ad 100 g.
HIRUDOID Gel:
Isopropylalcolhol - Propylene Glycol - Sodium hydroxide - Carbomer - Synthetic Perfume (Derog. n ° 42/1013) - Purified water qs ad 100 g.
4.5 Interaction with other medicinal products and other forms of interaction
Do not combine with other topica application.
6.2 Incompatibilities
Not applicable.
- Delivery form
- Cream
- Type of product
- Medicine
- Brands
- Neocare